Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04262869
Title Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University

lung non-small cell carcinoma


Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Paclitaxel


Age Groups: adult | senior
Covered Countries

No variant requirements are available.